ArticleOrthopaedic journal of sports medicine2026
Low Failure Rates and Favorable Outcomes of Meniscal Repair With Concomitant Anterior Cruciate Ligament Primary Repair at Minimum 2-Year Follow-up.
Article in Orthopaedic journal of sports medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Arthroscopic anterior cruciate ligament (ACL) primary repair (ACLPR) has reemerged as a treatment option for select proximal ACL tears. However, concerns persist regarding its ability to restore knee stability adequately to support meniscal healing after concurrent meniscal repair. Purpose: To evaluate the clinical outcomes after medial and/or lateral meniscus repair in patients undergoing ACLPR, compared with isolated ACLPR (ACLPR-only) and ACLPR with partial meniscectomy (ACLPR-PME). Study Design: Cohort study; Level of evidence, 3. Methods: Consecutive patients with complete, proximal modified Sherman type 1 and 2 ACL tears who underwent ACLPR between 2008 and 2021 with a minimum 2-year follow-up were included. Patients were categorized into 3 groups: ACLPR-only, ACLPR with meniscal repair (ACLPR-MR), and ACLPR-PME. The primary outcome was the International Knee Documentation Committee (IKDC) Subjective Knee Form score. Secondary outcomes consisted of meniscal repair and ACLPR failure, overall reoperation rates, anterior tibial translation side-to-side difference (ATT SSD), clinical outcomes (Lachman test and pivot-shift test results), and patient-reported outcome measures (PROMs) including the Lysholm score, Forgotten Joint Score-12, Anterior Cruciate Ligament Return to Sport after Injury score, and Tegner activity scale score. Results: A total of 276 patients (ACLPR-only: n = 131; ACLPR-MR: n = 76; ACLPR-PME: n = 69) with a mean age of 39.7 ± 10.7 years (50.4% female) and mean follow-up of 2.9 ± 1.0 years were included (7.4% lost to follow-up). The mean IKDC scores demonstrated no significant difference between groups (ACLPR-only: 89.4 ± 10.3 [95% CI, 87.2-91.6]; ACLPR-MR: 86.7 ± 12.9 [95% CI, 83.6-89.8]; ACLPR-PME: 89.2 ± 9.9 [95% CI, 86.6-91.9]; Conclusion: Meniscal repair with ACLPR is not associated with inferior clinical and patient-reported outcomes at the 2-year follow-up when compared with ACLPR-only and ACLPR-PME, with ACLPR-MR demonstrating a meniscal reinjury rate of 10.5%. These findings suggest that ACLPR provides sufficient knee stability to support clinically successful meniscal healing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.